A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a.
about
Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cellsThe future of high-grade glioma: Where we are and where are we going.Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for glioma?Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment
P2860
A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel therapeutic strategy f ...... molecular targeting of hsp90a.
@en
A novel therapeutic strategy f ...... molecular targeting of hsp90a.
@nl
type
label
A novel therapeutic strategy f ...... molecular targeting of hsp90a.
@en
A novel therapeutic strategy f ...... molecular targeting of hsp90a.
@nl
prefLabel
A novel therapeutic strategy f ...... molecular targeting of hsp90a.
@en
A novel therapeutic strategy f ...... molecular targeting of hsp90a.
@nl
P2093
P2860
P356
P1433
P1476
A novel therapeutic strategy f ...... molecular targeting of hsp90a.
@en
P2093
Amal Shervington
Chinmay Munje
Leroy Shervington
P2860
P304
P356
10.3390/CANCERS3044228
P577
2011-12-08T00:00:00Z